These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14323357)

  • 1. [STUDY ON LIVER TOLERANCE TO N-(4-MORPHOLINOMETHYL-PYRAZINAMIDE) IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
    BARRAS G
    Ther Umsch; 1964 Oct; 21():398-9. PubMed ID: 14323357
    [No Abstract]   [Full Text] [Related]  

  • 2. [EFFECT OF PYRAZINAMIDE ON INACTIVE DUODENAL ULCER].
    SERI I; KOLUMBAN K; BALOGH Z
    Tuberk Tudobetegsegek; 1964 May; 17():139-42. PubMed ID: 14186519
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE LIVER AND TUBERCULOSIS].
    PANA C
    Epatologia; 1963; 9():391-403. PubMed ID: 14090654
    [No Abstract]   [Full Text] [Related]  

  • 4. SOME PROBLEMS IN THE MANAGEMENT OF TUBERCULOSIS.
    MITCHELL JH
    Br J Clin Pract; 1964 Feb; 18():63-8. PubMed ID: 14115576
    [No Abstract]   [Full Text] [Related]  

  • 5. [ON HEPATITIS IN PULMONARY TUBERCULOSIS PATIENTS].
    ZADOR A; NAGY G; GEVICSER P; KLIMENKO O
    Tuberk Tudobetegsegek; 1963; 16():147-9. PubMed ID: 14054916
    [No Abstract]   [Full Text] [Related]  

  • 6. ETHIONAMIDE AND HEPATOTOXICITY: A CLINICAL STUDY.
    EL-KHOURY SA; DUNMORE LA
    Med Ann Dist Columbia; 1964 Jan; 33():15-7. PubMed ID: 14116699
    [No Abstract]   [Full Text] [Related]  

  • 7. [ENZYMATIC STUDY OF THE LIVER IN PULMONARY TUBERCULOSIS. RESEARCH ON A POSSIBLE HEPATOTOXIC EFFECT OF ANTIBACTERIAL MEDICATIONS].
    VULLIEMOZ P; FAVEZ G
    Med Thorac; 1964; 21():99-125. PubMed ID: 14225438
    [No Abstract]   [Full Text] [Related]  

  • 8. [CHANGES IN HEPATIC FUNCTION DURING ANTIBACTERIAL CHEMOTHERAPY].
    MARIANI B
    Bull Int Union Tuberc; 1964 Sep; 35():122-32. PubMed ID: 14269359
    [No Abstract]   [Full Text] [Related]  

  • 9. [APROPOS OF ETHIONAMIDE JAUNDICE].
    COTTIN S; COZAN R; VERAN P
    Poumon Coeur; 1964; 20():303-18. PubMed ID: 14167904
    [No Abstract]   [Full Text] [Related]  

  • 10. [EXPERIENCES WITH SPECIFIC CHEMOTHERAPY OF PULMONARY TUBERCULOSIS].
    LEHR G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1964 May; 128():218-41. PubMed ID: 14217711
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PRELIMINARY FUNCTIONAL AND MORPHOLOGICAL HEPATIC FINDINGS IN PATIENTS TREATED WITH MORPHAZINAMIDE].
    GRECO S; DUSI U; MENOZZI V
    Riv Anat Patol Oncol; 1963 May; 23():LXVII-LXXII. PubMed ID: 14083537
    [No Abstract]   [Full Text] [Related]  

  • 13. [NEW DRUGS IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
    LESTON JM
    Torax; 1963; 12():138-42. PubMed ID: 14159777
    [No Abstract]   [Full Text] [Related]  

  • 14. [MORPHAZINAMIDE IN ANTUBERCULAR THERAPY].
    FOUQUET J; TEYSSIER L
    G Ital Chemioter; 1963; 10():164-70. PubMed ID: 14079399
    [No Abstract]   [Full Text] [Related]  

  • 15. [ASSOCIATION OF 4,4'-DIISOAMYLOXYTHIOCARBANILIDE AND PYRAZINAMIDE, AND 4,4'-DIISOAMYLOXYTHIOCARBANILIDE AND KANAMYCIN IN THE TREATMENT OF PULMONARY TUBERCULOSIS CAUSED BY BACTERIA RESISTANT TO THE 1ST LINE DRUGS].
    PEREZ JA; FARIAS CE; BRONSTEIN DL; CONTRERAS H; MUNARO N
    Sem Med; 1964 Mar; 124():549-54. PubMed ID: 14158157
    [No Abstract]   [Full Text] [Related]  

  • 16. [APROPOS OF TOXIC AND EPIDEMIC HEPATITIS IN PATIENTS WITH TUBERCULOSIS DURING THERAPY WITH ANTIBACTERIAL PREPARATIONS].
    BODAREV VKh; RYBALKO VV
    Probl Tuberk; 1964; 42():85-7. PubMed ID: 14321028
    [No Abstract]   [Full Text] [Related]  

  • 17. [AMBULATORY AND HOSPITAL THERAPY OF TUBERCULOSIS].
    TANNER E
    Schweiz Med Wochenschr; 1964 Jun; 94():848-52. PubMed ID: 14250319
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effectiveness of pyrazinamide-containing six-month short course chemotherapy].
    Wada M
    Kekkaku; 2000 Nov; 75(11):665-73. PubMed ID: 11140090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
    SCHLESS JM; ALLISON RF; INGLIS RM; WHITE EF; TOPPERMAN S
    Am Rev Respir Dis; 1965 May; 91():728-37. PubMed ID: 14280946
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacology, toxicology and clinical use of pyrazinamide (author's transl)].
    Zierski M
    Prax Klin Pneumol; 1981 Dec; 35(12):1075-1105. PubMed ID: 6808484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.